Tirofiban Hydrochloride Injection, Solution
Product Images NDC 25021-417

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tirofiban Hydrochloride (NDC 25021-417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tir03 0000 01)

Chemical structure diagram of tirofiban hydrochloride, showing its molecular arrangement with labeled functional groups, including a piperidine ring, phenyl group, carboxylic acid, and sulfonamide moieties.*

FDA Label Image

Figure (Tir03 0000 02)

A line graph showing a composite endpoint over 180 days of follow-up comparing Heparin alone and Tirofiban Hydrochloride Injection plus Heparin. The y-axis represents the proportion with the endpoint, and the x-axis shows the study days from 0 to 180. Labels indicate a 22% risk reduction at an early point and a 19% risk reduction at day 180 for Tirofiban Hydrochloride Injection plus Heparin compared to Heparin alone.*

FDA Label Image

Package Label – Principal Display Panel – Bag Label (Tir03 0000 03)

Label for Tirofiban Hydrochloride Injection, 12.5 mg per 250 mL (50 mcg per mL) solution for intravenous use in a 250 mL single-dose container. The label includes storage instructions, cautions, and manufacturing details by Sagent Pharmaceuticals, Schaumburg, IL, made in India. The product is sterile, preservative-free, and recommended for use with a calibrated infusion device.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.